Zhenfeng Duan

Zhenfeng Duan

Auto-generated profile, based on publicly available information

Zhenfeng Duan

Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2012 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ZDZhenfeng Duan
Zhenfeng Duan
XLXin Li
Xin Li
HHHaoxi Huang
Haoxi Huang
WYWei Yuan
Wei Yuan
SZShao-Liang Zheng
Shao-Liang Zheng
FHFrancis Hornicek
Francis Hornicek

1 June 2009
Verified
Journal Article
Closed access
JSJoseph Schwab
Joseph Schwab
CACristina Antonescu
Cristina Antonescu
PBPatrick Boland
Patrick Boland
JHJohn Healey
John Healey
ARAndrew Rosenberg
Andrew Rosenberg
ZDZhenfeng Duan
Zhenfeng Duan

1 November 2010
Verified
Journal Article
Closed access
YGYu-Qi Guo
Yu-Qi Guo
PLPing Lu
Ping Lu
ZDZhen-Feng Duan
Zhen-Feng Duan
ZZZhan Zhang
Zhan Zhang

31 October 2009 in The Spine Journal
Verified
Journal Article
Closed access
CYCao Yang
Cao Yang
FHFrancis Hornicek
Francis Hornicek
KWKirkham Wood
Kirkham Wood
JSJoseph Schwab
Joseph Schwab
ECEdwin Choy
Edwin Choy
ZDZhenfeng Duan
Zhenfeng Duan

1 October 2010 in Current Enzyme Inhibition
Verified
Journal Article
Closed access
PDF file
MSMichiro Susa
Michiro Susa
FHFrancis J. Hornicek
Francis J. Hornicek
XLXianzhe Liu
Xianzhe Liu
ZDZhenfeng Duan
Zhenfeng Duan
Improvements in surgical technique, chemotherapy, and radiation have improved the prognosis of sarcoma patients, but it has since plateaued in recent years. Novel approaches are desperately needed for improved prognosis in the remaining patients. Targeting underlying molecular events have provided striking effects in some sarcomas. Signal transducers and activators of transcription 3 (STAT3) is a member of transcription factors that are activated by phosphorylation in the cytoplasm which are then translocated to the nucleus to regulate various gene expressions. STAT3 has been reported to be constitutively phosphorylated in various human cancers and has been cited as one of the instigators of neoplastic transformation. STAT3 and its associated signaling systems have been linked with resistance to chemotherapy and apoptosis suppression. These findings implicate to the possibility of targeting STAT3 for therapeutic intervention. This review provides an overview of STAT3 as a potential therapeutic target in the treatment of sarcoma.